BioNTech SE Weighted Average Share Price Share Options Granted2019
BioNTech SE (BNTX) reported Weighted Average Share Price Share Options Granted2019 of 157.24 EUR/shares for the 1-month period ending 2022-05-31, per its 20-F filed 2025-03-10.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 · last filed 2025-03-10
- 2022-05-31: Weighted Average Share Price Share Options Granted2019 1 month 157.24 EUR/shares; Weighted Average Share Price Share Options Granted2019 1 month as first filed 147.84 EUR/shares.
- 2021-05-17: Weighted Average Share Price Share Options Granted2019 190.87 EUR/shares; Weighted Average Share Price Share Options Granted2019 as first filed 179.46 EUR/shares.
- 2021-05-12: Weighted Average Share Price Share Options Granted2019 179.16 EUR/shares; Weighted Average Share Price Share Options Granted2019 as first filed 168.44 EUR/shares.
- 2020-02-29: Weighted Average Share Price Share Options Granted2019 1 month 28.20 EUR/shares.
| Period end | Weighted Average Share Price Share Options Granted2019 | Weighted Average Share Price Share Options Granted2019 as first filed | Weighted Average Share Price Share Options Granted2019 1 month | Weighted Average Share Price Share Options Granted2019 1 month as first filed |
|---|---|---|---|---|
| 2022-05-31 | 157.24 EUR/shares 20-F · filed 2025-03-10 | 147.84 EUR/shares 20-F · filed 2024-03-20 | ||
| 2021-05-17 | 190.87 EUR/shares 20-F · filed 2025-03-10 | 179.46 EUR/shares 20-F · filed 2024-03-20 | ||
| 2021-05-12 | 179.16 EUR/shares 20-F · filed 2025-03-10 | 168.44 EUR/shares 20-F · filed 2024-03-20 | ||
| 2020-02-29 | 28.20 EUR/shares 20-F · filed 2025-03-10 |